Literature DB >> 1351216

HCV genotypes in chronic hepatitis C and response to interferon.

K Kanai, M Kako, H Okamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1351216     DOI： 10.1016/0140-6736(92)91311-u

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  45 in total

1.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 2.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Subtyping of hepatitis C virus isolates by a line probe assay using hybridization.

Authors:  A Andonov; R K Chaudhary
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

4.  Predominance of hepatitis C virus genotype 1b in Bulgaria.

Authors:  A Andonov; P Teoharov; S Bakalova
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

5.  Duration of HCV infection as a predictor of nonresponse to interferon.

Authors:  A Craxì; V Di Marco; C Cammà; P Almasio; S Magrin
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 6.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

7.  Expression of interferon-alpha/beta receptor protein in liver of patients with hepatitis C virus-related chronic liver disease.

Authors:  Xiang-Wei Meng; Bao-Rong Chi; Li-Gang Chen; Ling-Ling Zhang; Yan Zhuang; Hai-Yan Huang; Xun Sun
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

8.  Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology.

Authors:  J Detmer; R Lagier; J Flynn; C Zayati; J Kolberg; M Collins; M Urdea; R Sánchez-Pescador
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Efficacy of combination therapy with interferon and azidothymidine in chronic type C hepatitis: a pilot study.

Authors:  M Tsutsumi; A Takada; M Sawada
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

10.  A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients.

Authors:  Muhammad Idrees; Sheikh Riazuddin
Journal:  BMC Gastroenterol       Date:  2009-01-20       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.